BELLICUM PHARMACEUTICALS, INC — Form D/A

BELLICUM PHARMACEUTICALS, INC of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2013-10-16. The offering totals $35.0M, of which $19.6M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2013-10-16
• Form: D/A
• Accession: 0001358403-13-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $35.0M
• Amount sold: $19.6M
• Remaining: $15.4M
• Minimum investment: $1.0M
• Investors: 21
• Date of first sale: 2011-11-09
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-175419

Issuer

• Name: BELLICUM PHARMACEUTICALS, INC
• CIK: 0001358403
• Entity type: Corporation
• Jurisdiction: DE
• Incorporated: 2004
• Address: 6400 FANNIN, HOUSTON, TX, 77030
• Phone: 7133416470

Officers, directors & promoters (17)

Other filings by this issuer (5)

More

• CIK 1358403 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search